Biotechnology Focus Podcast

  Mario Lebrun, former BIO Quebec managing director passes away, Mylan introduces three generic drugs for HIV, and Shire Pharma’s Onivide has been approved for metastatic adeno carcinoma of the pancreas. In this week’s Biotechnology Focus Podcast, we observe the passing of Mario Lebrun. The former managing director of BIO Quebec succumbed to cancer earlier this month. In other news, Mylan of the Netherlands announced it is rolling out in Canada, three generic drugs for the treating HIV. Shire Pharma Canada ULC said its injectable drug Onivyde has been approved for the treatment of metastatic adeno carcinoma of the pancreas. The read the whole stories, please click on the links below: MARIO LEBRUN FORMER BIO QUEBEC MANAGING DIRECTOR PASSES AWAY MYLAN INTRODUCES THREE HIV DRUGS IN CANADA ONIVYDE APPROVED FOR TREATMENT OF PANCREATIC CANCER: SHIRE PHARMA